CORRECTION article
Front. Oncol.
Sec. Breast Cancer
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1658958
Advanced (non-metastatic) triple negative breast cancer - An open label Phase 2 Randomized controlled trial
Provisionally accepted
- HealthCare Global Enterprises Ltd (HCG), Bangalore, India
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
In the published article, there was an error in affiliation(s) [first and third author]. Instead of "[Sammprada cancer hospital]", it should be "[Healthcare Global, Bangalore, India]".The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. In the published article, there was an error regarding the affiliation(s) for [Name of Author]. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated. In the published article, there was an error in the article title. Instead of " [Insert INCORRECT version]", it should be "[Insert CORRECT version]".
Keywords: Metformin, survival analysis, Triple negative breast cancer, clinical benefit, drug repurposing
Received: 03 Jul 2025; Accepted: 07 Jul 2025.
Copyright: © 2025 Ramani, Sadashivaiah and Naik. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Vinod Ramani, HealthCare Global Enterprises Ltd (HCG), Bangalore, India
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.